Rapid Risk Assessment: Outbreak of circulating vaccine-derived poliovirus type 1 in Ukraine, 4 September 2015
This risk assessment was triggered by two cases of paralytic poliomyelitis in children, caused by circulating vaccine-derived poliovirus type 1 (cVDPV1) in Ukraine during June and July 2015.
Rapid risk assessment: International spread of wild-type poliovirus in 2014 declared a Public Health Emergency of International Concern under the International Health Regulations (IHR) – May 2014
This rapid risk assessment examines the implications of the temporary recommendations for EU Member States and assesses whether the developments leading to the declaration of a PHEIC represent an increased risk of WPV importation to Member States of the European Union.
Risk of introduction and transmission of wild-type poliovirus in EU/EEA countries following events in Israel and Syria – updated risk assessment (9 December 2013)
The confirmed circulation of wild-type poliovirus (WPV) in Israel and the outbreak of poliomyelitis in Syria mean that there is a high risk the disease will be reintroduced into the EU/EEA.
Suspected outbreak of poliomyelitis in Syria: Risk of importation and spread of poliovirus in the EU
Following the announcement by WHO of a cluster of cases of acute flaccid paralysis in Syria, ECDC conducted a risk assessment and concludes that this does pose a risk that polio might be imported to the EU. The Risk Assessment includes number of recommendations for EU Member States.
Risk assessment: Wild-type poliovirus 1 transmission in Israel – what is the risk to Europe?
The EU/EEA countries and the rest of the WHO European Region, have been officially polio-free since 2002. However, wild-type polio virus 1 (WPV1) has been isolated in sewage and in the faeces of asymptomatic carriers in Israel since February 2013. In this risk assessment ECDC looks at the potential impact of this public health event on the risk of poliovirus being imported and re-established into circulation in EU/EEA.